FDA — authorised 17 July 1998
- Application: NDA020822
- Marketing authorisation holder: ABBVIE
- Status: supplemented
FDA authorised Celexa on 17 July 1998
Yes. FDA authorised it on 17 July 1998; FDA has authorised it.
ABBVIE holds the US marketing authorisation.